Skip to content

Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure

Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00804999
Enrollment
51
Registered
2008-12-09
Start date
2008-11-01
Completion date
2009-03-01
Last updated
2018-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Contact Lens Wear

Keywords

confocal microscopy, contact lens wear, contact lens solutions, sodium fluorescein

Brief summary

Assess the usefulness of using confocal microscopy to examine changes to the structure of the cornea and to identify any potential consequences of contact lens wear and/or solution use.

Detailed description

Several types of solutions are used in contact lens wear. Each contact lens solution used to disinfect contacts have different ingredients even though they all disinfect the contacts. The objective of this study is to examine the layers of the cornea via HRT in order to assess the usefulness of this technology and to identify any potential consequences of contact lens wear and/or care solution used.

Interventions

neutralized Clear Care

DRUGReNu

overnight soak in solution

overnight soak in solution

Sponsors

Alcon Research
CollaboratorINDUSTRY
Christine Sindt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Vision correctable to 20/30 or better in both eyes * Successful soft contact lens wear for at least 2 weeks prior to enrollment

Exclusion criteria

* History of hypersensitivity to any of the components in any of the lens solutions * One functional eye or a monofit lens * Any abnormal slit-lamp finding at baseline * Use of topical ocular meds * Any systemic condition with significant ocular side effects or that interfere with contact lens wear * Enrollment of the investigator's office staff, relatives or members of their respective households * Enrollment of more than one member of the same household

Design outcomes

Primary

MeasureTime frameDescription
HRT Corneal Scanbaseline and 2 hoursLooking for cell density

Countries

United States

Participant flow

Participants by arm

ArmCount
Non Contact Lens Wearers Using Clear Care
neutralized Clear Care and no contact lens wear Clear Care: neutralized Clear Care
15
Overnight Soaking With Renu
ReNu with and without sodium fluorescein ReNu MultiPlus MPS: overnight soak in solution
12
Overnight Soaking in Optifree
RepleniSH with and without sodium fluorescein ReNu MultiPlus MPS: overnight soak in solution OPTI-FREE RepleniSH MPDS: overnight soak in solution
14
Overnight Soaking in Optifree Replinish
ReNu and RepleniSH OPTI-FREE RepleniSH MPDS: overnight soak in solution
10
Total51

Baseline characteristics

CharacteristicNon Contact Lens Wearers Using Clear CareOvernight Soaking With RenuOvernight Soaking in OptifreeOvernight Soaking in Optifree ReplinishTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
15 Participants12 Participants14 Participants10 Participants51 Participants
Region of Enrollment
United States
15 Participants12 Participants14 Participants10 Participants51 Participants
Sex: Female, Male
Female
13 Participants11 Participants13 Participants9 Participants46 Participants
Sex: Female, Male
Male
2 Participants1 Participants1 Participants1 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 120 / 140 / 10
other
Total, other adverse events
0 / 150 / 120 / 140 / 10
serious
Total, serious adverse events
0 / 150 / 120 / 140 / 10

Outcome results

Primary

HRT Corneal Scan

Looking for cell density

Time frame: baseline and 2 hours

ArmMeasureGroupValue (MEAN)Dispersion
Non Contact Wearing Using Clear CareHRT Corneal ScanBaseline85 cells/mm^3Standard Deviation 112
Non Contact Wearing Using Clear CareHRT Corneal ScanTwo hours87 cells/mm^3Standard Deviation 110
Overnight Soaking With RenuHRT Corneal ScanTwo hours65 cells/mm^3Standard Deviation 48
Overnight Soaking With RenuHRT Corneal ScanBaseline66 cells/mm^3Standard Deviation 44
Overnight Soaking in OptifreeHRT Corneal ScanBaseline49 cells/mm^3Standard Deviation 28
Overnight Soaking in OptifreeHRT Corneal ScanTwo hours51 cells/mm^3Standard Deviation 32
Overnight Soaking in Optifree ReplinishHRT Corneal ScanBaseline63 cells/mm^3Standard Deviation 81
Overnight Soaking in Optifree ReplinishHRT Corneal ScanTwo hours61 cells/mm^3Standard Deviation 77

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026